Capstone Financial Advisors, Inc. Bristol Myers Squibb CO Transaction History
Capstone Financial Advisors, Inc.
- $1.62 Billion
- Q4 2024
A detailed history of Capstone Financial Advisors, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Capstone Financial Advisors, Inc. holds 17,849 shares of BMY stock, worth $1.09 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
17,849
Previous 22,434
20.44%
Holding current value
$1.09 Million
Previous $1.16 Million
13.02%
% of portfolio
0.06%
Previous 0.07%
Shares
18 transactions
Others Institutions Holding BMY
# of Institutions
2,761Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$11.6 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.69 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.87 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.81 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.68 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $130B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...